trending Market Intelligence /marketintelligence/en/news-insights/trending/ohsxxxdosp4xlyljqa7waw2 content esgSubNav
In This List

Cell MedX appoints board member to add medical device experience

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Cell MedX appoints board member to add medical device experience

Carson City, Nev.-based Cell MedX Corp. added George Adams to its board of directors.

Adams was previously CEO of Amorfix Life Sciences, which is known as ProMIS Neurosciences Inc.

The healthcare equipment company said Adams is experienced in bringing medical devices to global markets. Cell MedX develops medical devices for high blood pressure, diabetes and Parkinson's disease.